Detalles de la búsqueda
1.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Clin Exp Immunol
; 202(3): 353-362, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757277
2.
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first-line setting.
Cancer Rep (Hoboken)
; : e1966, 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148576
3.
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN.
ESMO Open
; 7(2): 100408, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279527
Resultados
1 -
3
de 3
1
Próxima >
>>